Xenon Pharmaceuticals XENE Unveils Robust Azetukalner Phase III Data Q3 NDA Filing Plans at Bloom Burton Conference Is Credicorp BAP stock showing strength Credicorp posts 94 EPS miss falling short of analyst estimates IPM Intelligent posts narrower than expected Q4 2025 loss yet shares dip 115 percent in todays trading